A heavy weight: Depression, SSRIs, and the phenomenology of the heart
Psychiatria Danubina · 17.11.2026 · 38 (3) · 329
DOI: 10.24869/psyd.2026.329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatria Danubina, online erschienen am 17.11.2026. Verfasst von Kelsee Frisbie. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Selective serotonin reuptake inhibitors (SSRIs) are the most common antidepressants used to treat depression. However, they can adversely affect the heart. Three SSRIs in particular cause cardiac problems: Citalopram, Sertraline, and Paroxetine. Citalopram can alter signals to the heart’s natural pacemaker, which is located in the upper wall of the right atrium. Sertraline can lower serotonin activity in the mitral valve. Paroxetine can cause lower recovery rate from a heart attack. Certain drugs must be evaluated more to determine if it is suitable to be prescribed to treat depression.
Zitieren
APA
Frisbie, K. (2026). A heavy weight: Depression, SSRIs, and the phenomenology of the heart. Psychiatria Danubina, 38(3), 329. https://doi.org/10.24869/psyd.2026.329
Vancouver
Frisbie K. A heavy weight: Depression, SSRIs, and the phenomenology of the heart. Psychiatria Danubina. 2026;38(3):329. doi:10.24869/psyd.2026.329
BibTeX
@article{Frisbie2026,
author = {Frisbie, Kelsee},
title = {A heavy weight: Depression, SSRIs, and the phenomenology of the heart},
journal = {Psychiatria Danubina},
year = {2026},
volume = {38},
number = {3},
pages = {329},
doi = {10.24869/psyd.2026.329}
}
EUVIMED